Central Bancompany heads into its May 1 Q1 results with the clearest signal sitting in the insider register, not the options market.
President and CEO John Ross put nearly $980,000 of his own money into CBC shares in February, buying 40,000 shares at $24.50. The stock has since risen roughly 6% to $25.89, and the 90-day net insider position is positive at roughly 41,000 shares across multiple buyers. That cluster of purchases — which also included the Executive Chairman and the General Counsel in November — reflects a management cohort that was actively adding exposure ahead of a reporting cycle, not trimming.
The short interest story is secondary but worth noting. Bearish positioning jumped sharply in April, with SI % of Free Float more than doubling over the month to just under 1%. That remains a thin position in absolute terms — fewer than 2.4 million shares. Availability is loose, borrow costs have eased back to 1.7% after briefly spiking above 6% in mid-April, and days to cover barely registers at 0.003 days. There is no squeeze pressure here. The ORTEX short score has climbed to 45 from 34 a fortnight ago, but the level is moderate. Options lean decisively the other way: the put/call ratio of 0.034 is well below its 20-day average of 0.078, meaning calls dominate the options book heading into the print.
The analyst community is broadly constructive. Morgan Stanley trimmed its target to $29 from $31 at the end of March while maintaining Overweight; Stephens assumed coverage with an Overweight and a $28 target in the same week. The mean target of $27.90 implies roughly 8% upside from current levels, a modest premium for a franchise that bulls describe as carrying an "unmatched ROA profile" with room to compound through acquisitions. Bears flag the credit-quality story as hard to sustain and point to slow loan growth as a ceiling on organic earnings momentum. The stock trades at 13.9x earnings and 1.5x book — valuations that have re-rated upward by roughly 10% over the past month, narrowing the margin of safety that made the February insider buys look opportunistic.
The May 1 print will test whether the fundamentals — particularly net interest margin and loan growth — are running ahead of or behind the pace embedded in that valuation re-rating.
See the live data behind this article on ORTEX.
Open CBC on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
